Clinical trial
Tranexamic Acid for Reduction of Intra- and Postoperative Transfusion Requirements in Elective Abdominal Surgery: Randomized Controlled Trial
NCT06414031 is registered in ClinicalTrials.gov with Ulrich Ronellenfitsch, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tranexamic Acid for Reduction of Intra- and Postoperative Transfusion Requirements in Elective Abdominal Surgery: Randomized Controlled Trial
- Lead sponsor
- Ulrich Ronellenfitsch, MD
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 17, 2024
- Completion date
- October 1, 2026
- Enrollment
- 892 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
abdomen disease, surgical blood loss, transfusion-dependent anemia